Skip to main content

Nabriva stock up after firm's antibiotic shows promise as a potential cystic fibrosis treatment

The company's stock opened up 9% Monday morning.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.